Furthermore, serum VEGF-D levels were elevated at baseline, decreased with sirolimus treatment, and correlated with kidney angiomyolipoma size (for a comparison of our VEGF-D results to several sporadic LAM studies, see Table S4). Here, VEGFD is linked to angiomyolipoma.